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We characterized 11 dengue virus (DENV) isolates 
obtained from Finnish travelers during 2000–2005 using 
monoclonal antibodies and phylogenetic analysis. The 
analysis of DENV isolated from travelers contributes to 
the global picture of strain distribution and circulation. The 
isolates included all serotypes, including a DENV-2 isolate 
from Ghana. 
D
engue viruses (DENV 1–4) are mosquito-borne mem-
bers of the family Flaviviridae, genus Flavivirus. Den-
gue is regarded as the most signiﬁ  cant arboviral disease in 
the world. Disease incidence and prevalence are rising in 
dengue-endemic areas, and travelers are increasingly af-
fected. The disease can vary from asymptomatic to febrile 
disease, classic dengue fever, or complications such as den-
gue hemorrhagic fever or dengue shock syndrome. Several 
virus- and host-speciﬁ  c factors have been suggested to cor-
relate with severe disease outcomes, which are mostly as-
sociated with secondary infections (1). These outcomes are 
not common in European travelers, and deaths are rare (2). 
In recent years, the number of annually diagnosed cases 
has increased in Finland from an average of 10 to >20 in 
2006 (Huhtamo et al., unpub. data). In the present study, 
samples collected during 1999–2005 were studied by virus 
isolation. Virus isolates were not obtained from year 1999 
samples; all isolates obtained from these samples were 
from the years 2000–2005. 
The Study
Patients returning from dengue-endemic areas with 
fever and other symptoms compatible with dengue were 
treated mainly at university hospitals in Finland. Because 
of clinical suspicion, serum samples were tested for anti-
bodies to DENV at Helsinki University Central Hospital 
Laboratory. The diagnosis was based on detection of im-
munoglobulin (Ig) M in the acute- or convalescent-phase 
sample or on a 4-fold IgG titer rise in paired serum speci-
mens in an in-house IgG immunoﬂ  uorescence assay (IFA), 
and IgM-enzyme immunoassay (Focus Technologies, Cy-
press, CA, USA). For this study, serum specimens from all 
patients were aliquoted and stored at –70ºC.  
From patients with dengue diagnosis, acute-phase se-
rum specimens with IgG titers <320 (IFA) were chosen for 
virus isolation (n = 40). Virus isolations were done simulta-
neously in 2 cell lines: in Vero E6 cells (ATCC CRL-1586) 
grown in minimal essential medium at 37°C and 5% CO2, 
and in C6/36 Aedes albopictus cells (ATCC CRL-1660) 
grown in Leibowitch L-15 medium at room temperature. 
Cells in 25-cm2 ﬂ  asks were incubated with 50 μL of patient 
serum for 1 hour and observed for 24 days for cytopathic 
effects (CPEs). When CPEs were evident, cells were har-
vested for IFA, and RNA was extracted from supernatants 
for reverse transcriptase–PCR (RT-PCR). In the absence 
of CPEs, cells were subcultured after 7 days into 75-cm2 
culture ﬂ  asks and studied by IFA on days 7 and 24. 
In IFA, the cells were stained with a DENV-positive 
serum and DENV–type-speciﬁ   c monoclonal antibodies 
(MAbs) (3). RNA was extracted from IFA- or CPE-posi-
tive culture supernatants with a Viral RNA Mini Kit (QIA-
GEN, Valencia, CA, USA) according to the manufacturer’s 
instructions. RT-PCR targeting the capsid–premembrane 
(C-preM) region was performed using DENV-speciﬁ  c 
primers (4), Expand reverse transcriptase (Roche, Basel, 
Switzerland) and Taq DNA polymerase (Fermentas, Glen 
Burnie, MD, USA). 
A total of 11 DENV strains were isolated from differ-
ent geographic locations, including the 4 serotypes (DENV-
1, n = 4; DENV-2, n = 2; DENV-3, n = 3; DENV-4, n = 2; 
Table). The serum samples yielding virus isolates were 
drawn within 1 week after onset of symptoms, which in-
cluded fever, headache, muscular pain, rash, and nausea. 
Most of these samples were positive for antibodies to 
DENV (IgM positive, n = 8; IgG positive, n = 5). 
Isolates were either strains that grew in both of the 
tested cell lines (n = 6) or strains that grew only in C6/36 
cells (n = 5). Two of the DENV-3 isolates (2 and 7) were 
detectable considerably earlier in Vero E6 than in C6/36 
cells. DENV-1 isolates showed 2 distinct growth patterns; 
isolates 4 and 8 grew only in C6/36 cells, and isolates 3 and 
11 grew in both tested cell lines (Table).
All isolates were successfully serotyped with the RT-
PCR of Lanciotti et al. (4), in agreement with results of 
the MAb IFA. However, isolate 3 (DENV-1) had particular 
properties in type-speciﬁ  c MAb IFA, depending on the cell 
type because it showed positive results in infected C6/36 
cells and negative results in infected VE6 cells. 
First-round RT-PCR amplicons were puriﬁ  ed by us-
ing ExoSAP-IT (US Biochemicals, Cleveland, OH, USA), 
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and directly sequenced. When necessary, the envelope 
gene was ampliﬁ  ed using previously described primers (5) 
and sequenced. Nucleotide sequences of the isolates were 
aligned with published DENV sequences from GenBank 
(online Appendix Table, available from www.cdc.gov/
EID/content/14/1/80-appT.htm) using ClustalW (www.ebi.
ac.uk/tools/clustalw). Phylogenetic analysis was performed 
by the neighbor-joining method with a Kimura 2-parameter 
model using MEGA3 software version 3.1 (6). 
Phylogenetic analyses (Figure 1) showed that iso-
lates 3, 4, and 8 (DENV-1) clustered with Asiatic DENV-
1 strains of genotype I (7), which corresponded with the 
patients’ travel history. Isolate 11 (DENV-1) from India 
clustered with a genotype III strain isolated a year earlier 
from the Seychelles. Isolate 6 (DENV-2), obtained from 
Sri Lanka in 2003, clustered with a strain isolated in the 
same year from India. Unlike the other isolates, isolate 9 
(DENV-2), obtained in Ghana in 2005, did not group with 
any of the representative strains of the C-preM region, for 
which no African sequences were available in GenBank. 
The additionally studied envelope gene sequence grouped 
with previous African isolates of the cosmopolitan geno-
type (8) (Figure 2).
The DENV-3 isolates represented genotype III (9) 
(Figure 1). Isolate 2 from Cuba clustered with strains from 
Martinique in agreement with previous data on Cuban 
strains (10). Isolate 7 (DENV-3), obtained in Sri Lanka in 
2004, clustered with strains from Singapore, Sri Lanka, and 
Taiwan. Isolate 5 was identical in sequence to a strain iso-
lated 1 year earlier from a patient in Brazil who died (11). 
DENV-4 isolates represented 2 different genotypes; isolate 
1 from Sri Lanka clustered with genotype I strains, and iso-
late 10 from Indonesia clustered with genotype II (12). 
Conclusions
Studies on imported DENV have provided interesting 
insights to the global picture of circulating strains (13,14), 
and also have led to the discovery of novel DENV strains 
and lineages (15,16). In this study, we characterized 11 
strains of DENV isolated from Finnish travelers in 2000–
2005 and provided new information about strains circulat-
ing in India, Sri Lanka, and Ghana. 
Previous studies have shown that DENV isolation is 
possible when antibody levels are low (17). However, in 
this study, most samples yielding virus isolates were anti-
body positive. The patients had primary infections, except 
for 1 patient, who had an IgG titer of 320 in the acute phase, 
which is suggestive of a secondary infection. This was the 
only patient with any bleeding symptoms, i.e., prolonged 
bleeding from the venopuncture site. 
Virus isolates from Finnish travelers were heteroge-
neous. All patients had dengue fever, including the patient 
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Table. Dengue virus isolates from Finnish travelers, 2000–2005* 
IFA screening of infected cells†
Vero E6 C6/36
Isolation serum 
antibody status Virus
serotype
Patient
travel
history Year
Isolate/
case no.
Strain designation 
(GenBank accession
 no.) dpi Pos dpi Pos dpo IgM IgG
Patient
sex/ 
age, y
DENV-1 Thailand 2002 3 F9.D1.02
(EU005250)
7 +++ 7 ++ 5 – <10 F/23
DENV-1 Malaysia/ 
Thailand
2002 4 F12.D1.02
(EU005249)
– – 24 + 7 + 20 F/43
DENV-1 Thailand 2005 8 F31.D1.05
(EU005248)
– – 24 + 7 + <10 F/56
DENV-1 India 2005 11 F37.D1.05
(EU005247)
5 +++ 5 +++ 3 NA NA M/31
DENV-2 Sri Lanka 2003 6 F18.D2.03
(EU005252)
– – 24 + 5 + 320 M/54
DENV-2 Ghana 2005 9 F32.D2.05
(C-preM, EU005251;
E, EU005258)
7 +++ 7 + 2 + <10 F/22
DENV-3 Cuba 2002 2 F7.D3.02
(EU005253)
7+ 2 4 + 6 +2 0 M / 5 5
DENV-3 Brazil 2003 5 F13.D3.03
(EU005254)
–– 2 4 + 5 + < 2 0 M / 2 6
DENV-3 Sri Lanka 2004 7 F24.D3.04
(EU005255)
4 +++ 24 + 2 – 20 F/39
DENV-4 Sri Lanka 2000 1 F2.D4.00
(EU005256)
10 +++ 10 + 4 + <10 F/42
DENV-4 Indonesia 2005 10 F34.D4.05
(EU005257)
–– 2 4 + 5 +2 0 M / 3 7
*IFA, immunofluoresence assay; dpi, day postinfection; Pos, proportion of positive cells; dpo, day post-onset; Ig, immunoglobulin; DENV, dengue virus; 
NA, not available; c-preM, capsid–premembrane; E, envelope. 
† +, ++, and +++ indicate the relative amount of positive cells observed in IFA using fluorescence microscope: individual positive cells observed <10% (+), 
10–50% of the cells positive (++), 50%–100% of the cells positive (+++). –, not detected. whose isolate was identical in sequence to a strain isolated 
from a patient who had died. Since the disease outcomes 
of the patients were uneventful, no associations could be 
made between the infective virus serotype or strain and dis-
ease severity. 
Both mammalian and mosquito cells were used in 
virus isolation, which enabled the detection of other ﬂ  a-
viviruses that may have caused seropositivity through 
cross-reaction. All DENV isolates grew in C6/36 mosqui-
to cells; however, use of 2 cell lines showed variation in 
the growth patterns of the isolates in different cell types. 
We observed that some DENV-3 strains were detectable 
earlier in mammalian Vero E6 cells than in C6/36 cells, 
which suggested a different capability to infect these cells. 
This property could not be associated with pathogenicity 
in this study; thus, the biologic relevance of this phenom-
enon is unknown. 
The DENV type-speciﬁ  c MAb IFA showed that one 
of the DENV-1 isolates (isolate 3) had distinct antigenic 
properties when cultured in mammalian or mosquito cells. 
Whether this strain represents MAb-escape properties re-
quires further studies. 
The phylogenetic grouping of the isolates was consis-
tent with the travel history of the patients in most cases. 
However, isolate 11 (DENV-1) from India clustered with 
a genotype III strain isolated a year earlier from the Sey-
chelles, which suggested strain transfer between these 
countries.
Phylogenetic analysis of isolate 9 (Ghana 2005) 
showed that it could be grouped with other African isolates 
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Figure 1. Neighbor-joining phylogenetic trees of the 4 dengue virus (DENV) serotypes based on the 454-bp capsid–premembrane (C-
preM) region sequences obtained from ﬁ  rst-round amplicons (6). Isolates described in this study are in circled. Bars represent nucleotide 
substitutions/site. Dengue Virus in Finnish Travelers
of the cosmopolitan genotype (Figure 2). To our knowl-
edge, this is the ﬁ  rst DENV-2 strain characterized from 
Ghana (the geographically nearest isolate is from Burkina 
Faso in 1983). This grouping demonstrates sustained circu-
lation of DENV-2 strains in Africa for decades.
The 11 DENV isolates represent a random sample 
from different geographic locations. Three strains were 
isolated from travelers returning from Sri Lanka, ﬁ  rst in 
2000 (DENV-4), followed by isolates in 2003 (DENV-2) 
and 2004 (DENV-3). These strains demonstrate extensive 
DENV serotype cocirculation.
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Figure 2. Neighbor-joining phylogenetic tree of dengue virus 
type 2 (DENV-2) based on the envelope gene sequence (1,485 
bp). Isolate 9 from Ghana is circled. Bar represents nucleotide 
substitutions/site.  